The Sea Venom, also called the Sea Venom/ANL from the French anti-navire leger meaning light anti-ship, is a helicopter-launched antiship cruise missile developed jointly by the French and British navies. It is designed for use against smaller, lighter ships such as fast attack vessels and corvettes, and it is intended to replace the British Sea Skua and the French AS15TT antiship weapons. The French defence minister announced the first successful test firing in a statement on 4 July 2017, describing a test on 21 June 2017 in which the 20 kilometre range missile was pushed to the very edge of its range capability according to the manufacturer's programme head. Further tests were planned to challenge the operator-in-the-loop capabilities of the missile, such as re-targeting and abort actions. The source is a short news item from 2017, so later service details are not covered here.
Facts
Weapon Class
Weapon Class (category) Classification
Service Status Introduced Year Connections
Operated By
Source Sea Venom (missile) (Wikipedia)
In the Other Atlases
Manufactured By
Also in Business Atlas: the manufacturer of this subject.
Source Sea Venom (missile) (Wikipedia)Infobox: manufacturerQuote, Infobox: manufacturer
MBDA
Originated In
Also in Geography Atlas: where this subject originated.
Source Sea Venom (missile) (Wikipedia)Infobox: originQuote, Infobox: origin
United Kingdom, France
Also in Geography Atlas: where this subject originated.
Source Sea Venom (missile) (Wikipedia)Infobox: originQuote, Infobox: origin
United Kingdom, France
Sources
1. Sea Venom (missile) (Wikipedia)
Lead section
Initial operating capability for the missile with the Royal Navy was declared in October 2025.
In Group: Anti-Ship and Anti-Submarine Missiles, Lead
Sea Venom is an Anglo-French lightweight anti-ship missile developed by MBDA to equip the French Navy and the Royal Navy.
View the Source2. Sea Venom (missile) (source article)
News item, openingQuote, News item, opening
a new helicopter-launched antiship cruise missile
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.